Abstract
Interleukin-33 (IL-33) is the most recently discovered IL-1 family member. Considered an endogenous “alarmin” released by necrotic cells in response to tissue injury or damage, IL-33 is constitutively expressed in tissues exposed to the environment, where endothelial and epithelial cells constitute its major sources. Several findings reported that pro-inflammatory stimuli, such as IFN-γ and TNF-α, as well as IL-17, can induce IL-33 expression in normal human epidermal keratinocytes. In the present study, we deeply investigated the relation between IL-33 and TNF-α, by employing the whole skin as study model. TNF-α dose- and time-dependently induced IL-33 gene expression in ex vivo healthy skin organ culture. Similarly, TNF-α significantly increased IL-33 mRNA expression in normal human epidermal sheets. Moreover, IL-33 was enhanced in psoriatic skin and anti-TNF-α therapy was able to significantly reduce it. The biology of IL-33 is gaining in complexity, and this molecule is now known to have additional roles beyond its original description. In particular, we can assess that IL-33 is regulated by TNF-α in normal and psoriatic skin.
This is a preview of subscription content, log in via an institution to check access.
References
Balato A, Schiattarella M, Lembo S, Mattii M, Prevete N, Balato N, Ayala F (2013) Interleukin-1 family members are enhanced in psoriasis and suppressed by vitamin D and retinoic acid. Arch Dermatol Res 305:255–262
Balato A, Lembo S, Mattii M, Schiattarella M, Marino R, De Paulis A, Balato N, Ayala F (2012) IL-33 is secreted by psoriatic keratinocytes and induces pro-inflammatory cytokines via keratinocyte and mast cell activation. Exp Dermatol 21:892–894
Balato A, Schiattarella M, Di Caprio R, Lembo S, Mattii M, Balato N, Ayala F (2013) Effects of adalimumab therapy in adult subjects with moderate-to-severe psoriasis on Th17 pathway. J Eur Acad Dermatol Venereol. doi:10.1111/jdv.12240
Bonish B, Jullien D, Dutronc Y, Huang BB, Modlin R, Spada FM, Porcelli SA, Nickoloff BJ (2000) Overexpression of CD1d by keratinocytes in psoriasis and CD1d-dependent IFN-γ production by NKT cells. J Immunol 165:4076–4085
Kempuraj D, Twait EC, Williard DE, Yuan Z, Meyerholz DK, Samuel I (2013) The novel cytokine interleukin-33 activates acinar cell proinflammatory pathways and induces acute pancreatic inflammation in mice. PLoS ONE 8:e56866
Kitano Y, Okada N (1983) Separation of the epidermal sheet by dispase. Br J Dermatol 108:555–560
Kobori A, Yagi Y, Imaeda H, Ban H, Bamba S, Tsujikawa T, Saito Y, Fujiyama Y, Andoh A (2010) Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis. J Gastroenterol 45:999–1007
Kunisch E, Chakilam S, Gandesiri M, Kinne RW (2012) IL-33 regulates TNF-α dependent effects in synovial fibroblasts. Int J Mol Med 29:530–540
Lefrançais E, Cayrol C (2012) Mechanisms of IL-33 processing and secretion: differences and similarities between IL-1 family members. Eur Cytokine Netw 23:120–127
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 4:402–408
Masamune A, Watanabe T, Kikuta K, Satoh K, Kanno A, Shimosegawa T (2010) Nuclear expression of interleukin-33 in pancreatic stellate cells. Am J Physiol Gastrointest Liver Physiol 299:G821–G832
Mattii M, Ayala F, Balato N, Filotico R, Lembo S, Schiattarella M, Patruno C, Marone G, Balato A (2013) The balance between pro- and anti-inflammatory cytokines is crucial in human allergic contact dermatitis pathogenesis: the role of IL-1 family members. Exp Dermatol 22:813–819
Meephansan J, Komine M, Tsuda H, Karakawa M, Tominaga S, Ohtsuki M (2013) Expression of IL-33 in the epidermis: the mechanism of induction by IL-17. J Dermatol Sci 71:107–114
Meephansan J, Tsuda H, Komine M, Tominaga S, Ohtsuki M (2012) Regulation of IL-33 expression by IFN-γ and tumor necrosis factor-α in normal human epidermal keratinocytes. J Invest Dermatol 132:2593–2600
Moussion C, Ortega N, Girard JP (2008) The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel ‘alarmin’? PLoS ONE 6:e3331
Préfontaine D, Lajoie-Kadoch S, Foley S, Audusseau S, Olivenstein R, Halayko AJ, Lemière C, Martin JG, Hamid Q (2009) Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J Immunol 183:5094–5103
Pushparaj PN, Tay HK, H’ng SC, Pitman N, Xu D, McKenzie A, Liew FY (2009) The cytokine interleukin-33 mediates anaphylactic shock. Proc Natl Acad Sci U S A 106:9773–9778
Ruifrok AC, Johnston DA (2001) Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Histol 23:291–299
Saidi S, Bouri F, Lencel P, Duplomb L, Baud’huin M, Delplace S, Leterme D, Miellot F, Heymann D, Hardouin P, Palmer G, Magne D (2011) IL-33 is expressed in human osteoblasts, but has no direct effect on bone remodeling. Cytokine 53:347–354
Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, Gorman DM, Bazan JF, Kastelein RA (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23:479–490
Seltmann J, Werfel T, Wittmann M (2013) Evidence for a regulatory loop between IFN-γ and IL-33 in skin inflammation. Exp Dermatol 22:102–107
Smithgall MD, Comeau MR, Yoon BP, Kaufman D, Armitage R, Smith DE (2008) IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen reactive Th2 cells, iNKT and NK Cells. Int Immunol 20:1019–1030
Trowell OA (1954) A modified technique for organ culture in vitro. Exp Cell Res 6:246–248
Wood IS, Wang B, Trayhurn P (2009) IL-33, a recently identified interleukin-1 gene family member, is expressed in human adipocytes. Biochem Biophys Res Commun 384:105–109
Conflict of interest
None declared.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Balato, A., Di Caprio, R., Canta, L. et al. IL-33 is regulated by TNF-α in normal and psoriatic skin. Arch Dermatol Res 306, 299–304 (2014). https://doi.org/10.1007/s00403-014-1447-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-014-1447-9